Welcure Drugs & Pharmaceuticals Ltd — Board Meeting, 02-09-2025: Board Meeting
02-09-2025 | 04:31 pm
02-09-2025 | 04:31 pm
Welcure Drugs' Board approved the FY25 Annual Report & MD&A. Key decisions included raising the FPI/FII/FDI/NRI investment limit to 49% of capital and expanding limits for loans/investments. A new Statutory Auditor was also appointed.
No comments yet. Be the first to comment!
